Icure Pharmaceutical Executive Cha Yun Sang Raises Shareholding to 3,000 Shares

PUBT · 1d ago
Icure Pharmaceutical Executive Cha Yun Sang Raises Shareholding to 3,000 Shares
  • Icure Pharmaceutical executive Cha Yun Sang bought 1,000 common shares on Nov. 2, 2026, at 1,342 won each.
  • His holding rose from 2,000 to 3,000 shares, representing a 0.01% stake as of Nov. 3.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Icure Pharmaceutical Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261103000331), on November 03, 2026, and is solely responsible for the information contained therein.